Qiu Z, Cheng L, Wang Q, Dong Z
Sex Med. 2025; 12(6):qfae091.
PMID: 39790564
PMC: 11710913.
DOI: 10.1093/sexmed/qfae091.
Rocha M, Cardoso A, Martins C, Mello M
Oncol Lett. 2024; 28(3):432.
PMID: 39049983
PMC: 11268092.
DOI: 10.3892/ol.2024.14563.
Bischof M, Stadelmann M, Janett S, Bianchetti M, Camozzi P, Goeggel Simonetti B
J Clin Med. 2023; 12(18).
PMID: 37762984
PMC: 10531745.
DOI: 10.3390/jcm12186044.
Shnayder N, Grechkina V, Khasanova A, Bochanova E, Dontceva E, Petrova M
Metabolites. 2023; 13(1).
PMID: 36677060
PMC: 9862929.
DOI: 10.3390/metabo13010134.
Anguissola G, Leu D, Simonetti G, Goeggel Simonetti B, Lava S, Milani G
Pediatr Nephrol. 2023; 38(6):1725-1731.
PMID: 36645492
PMC: 10154265.
DOI: 10.1007/s00467-022-05869-8.
The Neuroprotective Role of Acorus calamus in Developmental and Histopathological Changes in Autism-Induced Wistar Rats.
Ukkirapandian K, E K, Udaykumar K, Kandhi S, R M
Cureus. 2022; 14(9):e29717.
PMID: 36340563
PMC: 9621743.
DOI: 10.7759/cureus.29717.
Insights into Structural Modifications of Valproic Acid and Their Pharmacological Profile.
Kumar Mishra M, Kukal S, Paul P, Bora S, Singh A, Kukreti S
Molecules. 2022; 27(1).
PMID: 35011339
PMC: 8746633.
DOI: 10.3390/molecules27010104.
Valproic acid autoinduction: a case-based review.
Bennett S, Shad M
Int J Bipolar Disord. 2021; 9(1):27.
PMID: 34468892
PMC: 8408294.
DOI: 10.1186/s40345-021-00232-6.
Valproic Acid-Induced Liver Injury: A Case-Control Study from a Prospective Pharmacovigilance Program in a Tertiary Hospital.
Meseguer E, Elizalde M, Borobia A, Ramirez E
J Clin Med. 2021; 10(6).
PMID: 33801850
PMC: 7999396.
DOI: 10.3390/jcm10061153.
Differential Expression of Multiple Disease-Related Protein Groups Induced by Valproic Acid in Human SH-SY5Y Neuroblastoma Cells.
Hu T, Chung H, Ping L, Hsu S, Tsai H, Chen S
Brain Sci. 2020; 10(8).
PMID: 32806546
PMC: 7465595.
DOI: 10.3390/brainsci10080545.
The Anti-Tumorigenic Activity of Sema3C in the Chick Embryo Chorioallantoic Membrane Model.
Valiulyte I, Curkunaviciute R, Ribokaite L, Kazlauskas A, Vaitkeviciute M, Skauminas K
Int J Mol Sci. 2019; 20(22).
PMID: 31726800
PMC: 6888630.
DOI: 10.3390/ijms20225672.
Improving drug discovery using image-based multiparametric analysis of the epigenetic landscape.
Farhy C, Hariharan S, Ylanko J, Orozco L, Zeng F, Pass I
Elife. 2019; 8.
PMID: 31637999
PMC: 6908434.
DOI: 10.7554/eLife.49683.
Clinical Infections by Herpesviruses in Patients Treated with Valproic Acid: A Nested Case-Control Study in the Spanish Primary Care Database, BIFAP.
Gil M, Gonzalez-Gonzalez R, Vazquez-Calvo A, Alvarez-Gutierrez A, Martin-Acebes M, Praena B
J Clin Med. 2019; 8(9).
PMID: 31514402
PMC: 6780826.
DOI: 10.3390/jcm8091442.
Valproic Acid and Epilepsy: From Molecular Mechanisms to Clinical Evidences.
Romoli M, Mazzocchetti P, DAlonzo R, Siliquini S, Rinaldi V, Verrotti A
Curr Neuropharmacol. 2018; 17(10):926-946.
PMID: 30592252
PMC: 7052829.
DOI: 10.2174/1570159X17666181227165722.
Histone Deacetylase Inhibitors and Diabetic Kidney Disease.
Hadden M, Advani A
Int J Mol Sci. 2018; 19(9).
PMID: 30189630
PMC: 6165182.
DOI: 10.3390/ijms19092630.
PPARγ agonists: potential treatment for autism spectrum disorder by inhibiting the canonical WNT/β-catenin pathway.
Vallee A, Vallee J, Lecarpentier Y
Mol Psychiatry. 2018; 24(5):643-652.
PMID: 30104725
DOI: 10.1038/s41380-018-0131-4.
Combination Therapy with Sulfasalazine and Valproic Acid Promotes Human Glioblastoma Cell Death Through Imbalance of the Intracellular Oxidative Response.
Garcia C, Assad Kahn S, Geraldo L, Romano I, Domith I, Silva D
Mol Neurobiol. 2018; 55(8):6816-6833.
PMID: 29349577
DOI: 10.1007/s12035-018-0895-1.
Warburg effect hypothesis in autism Spectrum disorders.
Vallee A, Vallee J
Mol Brain. 2018; 11(1):1.
PMID: 29301575
PMC: 5753567.
DOI: 10.1186/s13041-017-0343-6.
Relevance of CYP2C9 Function in Valproate Therapy.
Monostory K, Nagy A, Toth K, Budi T, Kiss A, Deri M
Curr Neuropharmacol. 2017; 17(1):99-106.
PMID: 29119932
PMC: 6341495.
DOI: 10.2174/1570159X15666171109143654.
Valproate increases dopamine transporter expression through histone acetylation and enhanced promoter binding of Nurr1.
Green A, Zhan L, Eid A, Zarbl H, Guo G, Richardson J
Neuropharmacology. 2017; 125:189-196.
PMID: 28743636
PMC: 5585058.
DOI: 10.1016/j.neuropharm.2017.07.020.
